Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies

被引:14
|
作者
Brnabic, Alan [1 ]
Lin, Chaucer [2 ,3 ]
Monkul, E. Serap [4 ]
Duenas, Hector [5 ]
Raskin, Joel [6 ]
机构
[1] OPTUMInsight, Lilyfield, NSW 2040, Australia
[2] Eli Lilly Taiwan, Taipei, Taiwan
[3] Buddhist Tzu Chi Gen Hosp & Univ, Hualien, Taiwan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly Mexico, Mexico City, DF, Mexico
[6] Eli Lilly & Co, Toronto, ON, Canada
关键词
Major depressive disorder; Observational study; Painful physical symptoms; Pooled analysis; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; SYMPTOMATOLOGY IDS; SOMATIC SYMPTOMS; REMISSION; PREVALENCE; OUTCOMES; ASSOCIATION; RELIABILITY; DULOXETINE;
D O I
10.1185/03007995.2012.748654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This retrospective post-hoc analysis of observational studies assesses the frequency of painful physical symptoms (PPS) in patients with major depressive disorder (MDD) of varied severity as may be seen in clinical practice. Methods: Observational studies of MDD that collected a clinician-reported measure of depression severity and included assessment of PPS were screened for this individual patient-level analysis. Six observational studies were included that enrolled outpatients with a diagnosis of MDD (assessed using the 17-item Hamilton depression scale, Hospital Anxiety and Depression Scale-Depression, or Inventory of Depressive Symptomatology). Measures of PPS were based on the original study assessment (modified Somatic Symptom Inventory [SSI] and Visual Analogue Scale [VAS]). Patients were divided into analysis cohorts based on the presence or absence of PPS. To model PPS status, odds ratios were calculated from logistic regression for cross-sectional analysis (main analysis) and generalized linear mixed models for longitudinal models (exploratory longitudinal analysis). Results: For the main analysis, four studies (N = 2943, 71.6% female, mean age 45.3 years) were identified. Of 2901 eligible patients, 61.7% were classified as having painful physical symptoms (PPS+). At study entry, 73.1% (957/1309) of patients in the severe category of depression, 56.8% (537/945) of those with moderate depression, and 45.6% (295/647) of those with mild depression were PPS+. The exploratory longitudinal analysis was performed using a subset (N = 2430) from the studies used in the main analysis plus two others (an additional 7984 patients, 6742 of which were modeled). The likelihood of patients that were PPS- at baseline later developing PPS was 5% to 13% greater for patients with increased depression severity (P<0.001) and the likelihood of PPS+ patients later not having PPS was 9% to 17% less for patients with increased depression severity (P<0.0001). Conclusions: Since this is a retrospective aggregate analysis of several observational studies, and due to missing data, care should be taken in the interpretation of these results. Despite the use of adjustment techniques, selection bias and unmeasured confounding may still be an issue for comparative analysis as not all variables were collected for all studies. For patients treated in typical care settings, PPS were associated with depression severity. However, patients with mild and moderate depression also exhibited PPS. Clinicians should be aware that PPS are present, and may warrant treatment, across depression severities.
引用
收藏
页码:1891 / 1897
页数:7
相关论文
共 50 条
  • [31] Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
    Kuga, Atsushi
    Otsubo, Tempei
    Tsuji, Toshinaga
    Hayashi, Shinji
    Imagawa, Hideyuki
    Fujikoshi, Shinji
    Escobar, Rodrigo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 809 - 817
  • [32] The structure of depressive symptoms and characteristics and their relation to overall severity in major depressive disorder
    Miller, Chris H.
    Davis, Elena G.
    King, Lucy S.
    Sacchet, Matthew D.
    Grill-Spector, Kalanit
    Gotlib, Ian H.
    PSYCHIATRY RESEARCH, 2020, 294
  • [33] Reduction of anxiety symptoms in patients with major depressive disorder treated with Desvenlafaxine Succinate: A pooled analysis
    Tourian, K. A.
    Ahmed, S.
    Patroneva, A.
    Zitek, B.
    Graepel, J.
    Pitrosky, B.
    EUROPEAN PSYCHIATRY, 2008, 23 : S208 - S208
  • [34] Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study
    Ang, Q. Q.
    Wing, Y. K.
    He, Y.
    Sulaiman, A. H.
    Chiu, N. -Y.
    Shen, Y. -C.
    Wang, G.
    Zhang, C.
    Lee, K. -H.
    Singh, P.
    Granger, R. E.
    Raskin, J.
    Dossenbach, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (07) : 1041 - 1049
  • [35] The association between clinical outcomes and painful physical symptoms in East-Asian patients with major depressive disorder: A three-month observational study
    Raskin, J.
    Wing, Y. K.
    He, Y.
    Sulaiman, A. H.
    Chiu, N. -Y.
    Shen, Y. -C.
    Wang, G.
    Zhang, C.
    Lee, K. -H.
    Ang, Q. Q.
    Dossenbach, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 160 - 160
  • [36] Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
    Harada, Eiji
    Satoi, Yoichi
    Kikuchi, Toshiaki
    Watanabe, Koichiro
    Alev, Levent
    Mimura, Masaru
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1599 - 1607
  • [37] An IRT Analysis of the Symptoms of Major Depressive Disorder
    Emmert-Aronson, Benjamin O.
    Brown, Timothy A.
    ASSESSMENT, 2015, 22 (03) : 332 - 340
  • [38] Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder
    Brannan, SK
    Mallinckrodt, CH
    Brown, EB
    Wohlreich, MM
    Watkin, JG
    Schatzberg, AF
    JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (01) : 43 - 53
  • [39] Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study
    Sekine, Atsushi
    Hozumi, Satoshi
    Shimizu, Tetsuo
    PSYCHIATRY RESEARCH, 2016, 242 : 240 - 244
  • [40] Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy
    Thase, Michael E.
    Montgomery, Stuart
    Papakostas, George I.
    Bauer, Michael
    Trivedi, Madhukar H.
    Svedsaeter, Henrik
    Locklear, Julie C.
    Gustafsson, Urban
    Datto, Catherine
    Eriksson, Hans
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (03) : 113 - 120